Wouldn’t it be great if there were a magic food you could eat to prevent cancer? It turns out that this is not necessarily pie-in-the-sky thinking. In fact, healthy eating plays a significant role in cancer prevention, which is why Seattle Cancer Care Alliance (SCCA) offers nutrition visits at no charge to its patients.
In 1999, Patrick Barnes, 33 and a two-time survivor of Hodgkin’s disease, was diagnosed with a rare autoimmune bleeding disorder. He and his wife had just welcomed their first child, a daughter, weeks earlier.
Dr. Rachel Yung wants to be unemployed. As clinical director of breast cancer prevention and wellness at Seattle Cancer Care Alliance (SCCA), here’s what she really means: She wants to reduce the number of people diagnosed with cancer. For those who do develop cancer, she wants to minimize the amount of treatment they need. “I would love to be out of a job,” says Yung, a medical oncologist. “I think most oncologists feel this way.”
Seattle Cancer Care Alliance (SCCA) and Fred Hutch physicians and researchers who are leaders in in blood and marrow transplantation will present their research at the Transplantation and Cellular Therapy Meetings (TCT, formerly the BMT Tandem Meetings). TCT are the combined annual meetings of the American Society of Blood and Marrow Transplantation (ASBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR). The full scientific program addresses the most timely issues in hematopoietic cell transplantation for investigators, clinicians, laboratory technicians, clinical research professionals, nurses, pharmacists, administrators and allied health professionals who attend the meetings.
Seattle Cancer Care Alliance (SCCA), UW Medicine, and Fred Hutch physicians and researchers who are leaders in treating genitourinary cancers will attend and present their research at the Genitourinary Cancers Symposium taking place Feb. 14-16 in San Francisco. The symposium will feature an array of multidisciplinary sessions covering prostate, renal, urothelial, penile, testicular, and adrenal cancers. World-renowned faculty, including our own, will discuss the latest clinically relevant topics with a focus on multimodality therapy and value in cancer care.